HGSI, CAT in big antibody pact

Human Genome Sciences announced that it will invest $67 million in a broad alliance with Cambridge Antibody Technology (LSE:CAT) to develop human antibodies.

HGSI

Read the full 240 word article

How to gain access

Continue reading with a
two-week free trial.